Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA080957-03
Application #
6377078
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Okano, Paul
Project Start
1999-08-01
Project End
2004-05-31
Budget Start
2001-08-01
Budget End
2004-05-31
Support Year
3
Fiscal Year
2001
Total Cost
$194,157
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Tao, Xiang; Zhao, Naiqing; Jin, Hongyan et al. (2013) FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3. Endocr Relat Cancer 20:415-29
Huang, Shaoyi; Chang, In Soon; Lin, Wenbo et al. (2009) ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins. Biosci Rep 30:159-68
Feng, Weiwei; Marquez, Rebecca T; Lu, Zhen et al. (2008) Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 112:1489-502
Feng, Weiwei; Shen, Lanlan; Wen, Sijin et al. (2007) Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res 9:R57
Feng, Weiwei; Lu, Zhen; Luo, Robert Z et al. (2007) Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer. Int J Cancer 120:1664-8
Yu, Yinhua; Luo, Robert; Lu, Zhen et al. (2006) Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers. Methods Enzymol 407:455-68
Lu, Zhen; Luo, Robert Z; Peng, Hongqi et al. (2006) Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res 12:2404-13
Lu, Z; Luo, R Z; Peng, H et al. (2006) E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Oncogene 25:230-9
Rosen, Daniel G; Wang, Lin; Atkinson, J Neeley et al. (2005) Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol 99:267-77
Nishimoto, Arata; Yu, Yinhua; Lu, Zhen et al. (2005) A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells. Cancer Res 65:6701-10

Showing the most recent 10 out of 19 publications